In this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
Caitlin M. Sacco, PharmD Candidate
Advertisement
Articles by Caitlin M. Sacco, PharmD Candidate
Current cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.
Advertisement
Latest Updated Articles
Managing Hematologic Cancer Therapies and Reducing COVID-19 RiskPublished: April 3rd 2021 | Updated:
Improving Outcomes for Patients With Breast CancerPublished: February 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
3
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
4
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
5
